- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Elbit names Bird to head global ultrasound group
Vendor hopes for executive stability Israeli technology firm Elbit has named Thomas Bird to head ElbitUltrasound Group, the company's far-flung empire of ultrasoundfirms that includes Diasonics and Ausonics. Bird will fill theleadership vacuum
Vendor hopes for executive stability
Israeli technology firm Elbit has named Thomas Bird to head ElbitUltrasound Group, the company's far-flung empire of ultrasoundfirms that includes Diasonics and Ausonics. Bird will fill theleadership vacuum left by Diasonics CEO Bruce Moore, who leftthe company earlier this year (SCAN 2/15/95).
Elbit hopes Bird's arrival will put an end to speculation aboutits ultrasound leadership team, particularly in the executivesuites of Diasonics. After Moore's departure in January, ElbitCEO Emmanuel Gill stepped in to take Moore's place and promotedseveral executives at Diasonics headquarters in Santa Clara, CA.However, one of those executives, Omar Ishrak, left Diasonicsin May to head up the ultrasound business of GE Medical Systems(SCAN 6/7/95).
Bird has executive authority not only over Diasonics but alsoover the other companies in Elbit Ultrasound Group, which includesSonotron, Vingmed Sound, Ausonics and Elscintec. Bird will reportdirectly to Gill.
Bird comes to Diasonics from the consulting world. He was presidentand CEO of Management Concepts, a Los Angeles consulting firm,and specialized in the management of large global organizations.His ultrasound experience includes three years with Philips UltrasoundInternational.
Bird's goals will be to increase the group's market share inradiology and cardiology and to expand the company's presencein new market segments. For example, Diasonics recently forgeda link with sister company Elscint to increase its market penetrationin Canada. The deal essentially quadruples the number of salesreps selling Diasonics scanners in Canada.
Elbit Ultrasound Group hired Bird because it determined thata leadership presence was needed near Diasonics headquarters,according to David Kaufman, Diasonics vice president of salesand service for North America.
"For a day-to-day focus on the operations of the business,there needed to be somebody nearby," Kaufman said. "Wefelt we needed to have someone more closely allied with the organizationwith a full focus on the company."
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
